Surgical Treatment of Women with Breast Cancer and a BRCA1 Pathogenic Variant: An International Analysis of the Impact of Bilateral Mastectomy on Survival
 |
Prospective WSG phase III PlanB trial: Final analysis of adjuvant 4xEC→4x doc vs. 6x docetaxel/cyclophosphamide in patients with high clinical risk and intermediate-to-high genomic risk HER2-negative, early breast cancer
Comentários
Postar um comentário